Optimizing Medical Therapy of Acromegaly: Beneficial Effects of Cabergoline in Patients Uncontrolled with Long-Acting Release Octreotide

Publisher： Karger

E-ISSN： 1423-0194|90|1|82-92

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.90, Iss.1, 2009-05, pp. : 82-92

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Short- and Long-Term Efficacy of Combined Cabergoline and Octreotide Treatment in Controlling IGF-I Levels in Acromegaly

By  

Neuroendocrinology, Vol. 92, Iss. 2, 2010-08 ,pp. : 120-127

Karger

Access to resources Recommend Favorite

Impact of Octreotide Long-Acting Release on Tumour Growth Control as a First-Line Treatment in Neuroendocrine Tumours of Pancreatic Origin

By  

Neuroendocrinology, Vol. 98, Iss. 2, 2013-08 ,pp. : 137-143

Karger

Access to resources Recommend Favorite

Long-Acting Hydrocortisone for Glucocorticoid Replacement Therapy

By  

Hormone Research in Paediatrics, Vol. 68, Iss. 5, 2007-12 ,pp. : 182-188

Karger

Access to resources Recommend Favorite

Long-Term Remission of Acromegaly after Octreotide Withdrawal Is an Uncommon and Frequently Unsustainable Event

By  

Neuroendocrinology, Vol. 104, Iss. 3, 2016-05 ,pp. : 273-279

Karger

Access to resources Recommend Favorite

Long-Acting Forms of Growth Hormone-Releasing Hormone and Growth Hormone: Effects in Normal Volunteers and Adults with Growth Hormone Deficiency

By  

Hormone Research in Paediatrics, Vol. 68, Iss. 5, 2007-12 ,pp. : 178-181

Karger

Access to resources Recommend Favorite